top of page
  • Writer's pictureDLRG

Cornell team engineers better flu vaccine

Updated: Oct 30, 2021

Team's effort to engineer a universal flu vaccine that can be administered in a single shot is featured in IEEE Pulse article on vaccine innovation

The DeLisa and Putnam labs have teamed up for nearly a decade to develop novel vaccines based on bacterial outer membrane vesicles (OMVs), which are a membrane-based nanostructure, in this case engineered from nonpathogenic E. coli, whose outer surface mimics the cell from which it originated. Recently, the Putnam-DeLisa team, along with collaborator Gary Whittaker from the Department of Microbiology and Immunology at Cornell, leveraged the versatility of OMVs, which have shown promise against other deadly pathogens, to create a single-shot vaccine. A story on vaccine innovation featuring this work was published recently in IEEE Pulse:

Links to the original research article and the Cornell Chronicle article can be found at;

128 views0 comments


Commenting has been turned off.
bottom of page